Abeona Therapeutics ABEO
NASDAQ ABEO
$5.19 +0.03 (+0.58%)
As of: Sep 30, 2026 · 10:06 AM EDT

Abeona Therapeutics (ABEO) Current Leases (2019)

Updated

Abeona Therapeutics' Current Leases came in at $1.69 million for Q2 2019, up 0.2% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Current Leases (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Abeona Therapeutics 302.73 Mn -411.23 Mn 7.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 1.69 Mn
Mar 31, 2019 1.69 Mn
API Access

Abeona Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ABEO&period=max&api_key=YOUR_API_KEY